Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601

Watchlist Manager
Shenzhen Kangtai Biological Products Co Ltd Logo
Shenzhen Kangtai Biological Products Co Ltd
SZSE:300601
Watchlist
Price: 18.1 CNY -4.99% Market Closed
Market Cap: 20.2B CNY
Have any thoughts about
Shenzhen Kangtai Biological Products Co Ltd?
Write Note

Wall Street
Price Targets

Price Targets Summary
Shenzhen Kangtai Biological Products Co Ltd

Wall Street analysts forecast Shenzhen Kangtai Biological Products Co Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 21.84 CNY with a low forecast of 10.92 CNY and a high forecast of 35.37 CNY.

Lowest
Price Target
10.92 CNY
40% Downside
Average
Price Target
21.84 CNY
21% Upside
Highest
Price Target
35.37 CNY
95% Upside
Shenzhen Kangtai Biological Products Co Ltd Competitors:
Price Targets
BONEX
Bonesupport Holding AB
5% Upside
OCC
Orthocell Ltd
9% Downside
ACLX
Arcellx Inc
26% Upside
CPRX
Catalyst Pharmaceuticals Inc
52% Upside
AUPH
Aurinia Pharmaceuticals Inc
25% Upside
DVYSR
Devyser Diagnostics AB
12% Upside
ALLK
Allakos Inc
224% Upside
ORY
Oryzon Genomics SA
296% Upside

Revenue
Forecast

Revenue Estimate
Shenzhen Kangtai Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 10%.

29%
Past Growth
10%
Estimated Growth
Estimates Accuracy
-9%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Shenzhen Kangtai Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 38%. The projected CAGR for the next 3 years is 14%.

38%
Past Growth
14%
Estimated Growth
Estimates Accuracy
-20%
Average Miss

Net Income
Forecast

Net Income Estimate
Shenzhen Kangtai Biological Products Co Ltd

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 39%. The projected CAGR for the next 3 years is 0%.

39%
Past Growth
0%
Estimated Growth
Estimates Accuracy
11%
Average Beat

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Shenzhen Kangtai Biological Products Co Ltd's stock price target?
Price Target
21.84 CNY

According to Wall Street analysts, the average 1-year price target for Shenzhen Kangtai Biological Products Co Ltd is 21.84 CNY with a low forecast of 10.92 CNY and a high forecast of 35.37 CNY.

What is Shenzhen Kangtai Biological Products Co Ltd's Revenue forecast?
Projected CAGR
10%

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's revenue is 29%. The projected CAGR for the next 3 years is 10%.

What is Shenzhen Kangtai Biological Products Co Ltd's Operating Income forecast?
Projected CAGR
14%

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's operating income is 38%. The projected CAGR for the next 3 years is 14%.

What is Shenzhen Kangtai Biological Products Co Ltd's Net Income forecast?
Projected CAGR
0%

For the last 8 years the compound annual growth rate for Shenzhen Kangtai Biological Products Co Ltd's net income is 39%. The projected CAGR for the next 3 years is 0%.

Back to Top